Putting the award page together from the records…
Putting the award page together from the records…
Battelle Memorial Institute received this contract from National Institutes of Health Niaid, National Institutes of Health: $3.79M obligated so far for health r&d services; health care services; applied research. It runs to 2028-05-31.
Key facts · data as of Oct 23, 2026
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 23, 2026.
Cite this page: SpendQuery, Award 75N93019F00131, data as of Oct 23, 2026, https://spendquery.com/award?id=CONT_AWD_75N93019F00131_7529_75N93018D00013_7529
Battelle Memorial Institute: all federal awards · Department of Health and Human Services: spending · National Institutes of Health Niaid: what it buys · The follow-on: recompete brief
1800013I BATTELLE MEMORIAL INSTITUTE; IMMUNOGENICITY AND EFFICACY TESTING OF MEDICAL COUNTERMEASURES (VACCINES AND OTHER BIOLOGICS) AGAINST BSL-4 PATHOGENS IN NHPS; TO 2 BASE AWARD; BIOD CAN 8470038; $616,957
Up for re-bid: ends 2028-05-31. Recompete brief →
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
1 subaward totaling $1.28M (33.8% of what was obligated), as Battelle Memorial Institute reported them. Primes report subawards of $30,000 or more; smaller ones and unreported ones aren't here.
| Subcontractor | Amount | Subawards | Where | First | Last |
|---|---|---|---|---|---|
| Texas Biomedical Research Institute | $1.28M | 1 | TX | 2026-06-02 | 2026-06-02 |
| Date | To | Amount | For |
|---|---|---|---|
| 2026-06-02 | Texas Biomedical Research Institute | $1.28M | MARV STUDIES ON NHP'S |
6 actions since 2024-06-18. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-09-27 | P00013 | Funding only | -$216.0K | BATTELLE MEMORIAL INSTITUTE; IMMUNOGENICITY AND EFFICACY TESTING OF MEDICAL COUNTERMEASURES (VACCINES AND OTHER BIOLOGICS) AGAINST BSL-4 PATHOGENS IN NHPS; TO 2 |
| 2026-09-16 | P00012 | Option exercised | $2.40M | BATTELLE MEMORIAL INSTITUTE; IMMUNOGENICITY AND EFFICACY TESTING OF MEDICAL COUNTERMEASURES (VACCINES AND OTHER BIOLOGICS) AGAINST BSL-4 PATHOGENS IN NHPS; TO 2 |
| 2026-05-01 | P00011 | Supplemental agreement (work within scope) | $0 | BATTELLE MEMORIAL INSTITUTE; IMMUNOGENICITY AND EFFICACY TESTING OF MEDICAL COUNTERMEASURES (VACCINES AND OTHER BIOLOGICS) AGAINST BSL-4 PATHOGENS IN NHPS; TO 2 |
| 2025-12-15 | P00010 | Option exercised | $2.69M | BATTELLE MEMORIAL INSTITUTE; IMMUNOGENICITY AND EFFICACY TESTING OF MEDICAL COUNTERMEASURES (VACCINES AND OTHER BIOLOGICS) AGAINST BSL-4 PATHOGENS IN NHPS; TO 2 |
| 2025-09-22 | P00009 | Funding only | -$1.09M | BATTELLE MEMORIAL INSTITUTE; IMMUNOGENICITY AND EFFICACY TESTING OF MEDICAL COUNTERMEASURES (VACCINES AND OTHER BIOLOGICS) AGAINST BSL-4 PATHOGENS IN NHPS; TO 2 |
| 2024-06-18 | P00008 | Supplemental agreement (work within scope) | $0 | BATTELLE MEMORIAL INSTITUTE; IMMUNOGENICITY AND EFFICACY TESTING OF MEDICAL COUNTERMEASURES (VACCINES AND OTHER BIOLOGICS) AGAINST BSL-4 PATHOGENS IN NHPS; TO 2 |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-23). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗